Cross-cultural associations between behavioural, emotional, and cognitive differences in autistic children and parental wellbeing: evidence from five countries - Summary - MDSpire
Advertisement
Cross-cultural associations between behavioural, emotional, and cognitive differences in autistic children and parental wellbeing: evidence from five countries
To investigate the cross-cultural associations between emotional/behavioural and cognitive/adaptive differences in autistic children and parental wellbeing.
Approach:
Study Design: Cross-sectional, observational study using multinational data from parents of autistic children across five countries.
Participants: Data were obtained from 219 autistic children aged up to 18 years across Australia, Singapore, Hungary, Romania, and the United Kingdom.
Analysis: Multivariable logistic regression models examined associations between children’s autistic difficulties and parental wellbeing.
Key Findings:
Higher emotional/behavioural difficulties in children were significantly associated with lower parental QoL (AOR = 0.36, 95% CI 0.11-0.97) and increased parental stress (AOR = 2.11, 95% CI 1.08-4.54).
Cognitive/adaptive difficulties did not show a statistically significant association with parental QoL or stress.
No evidence of country- or measure-level heterogeneity for parental wellbeing outcomes, indicating consistent associations across cultures.
Interpretation:
Emotional and behavioural difficulties in autistic children are linked to poorer parental quality of life and increased stress across diverse cultures.
Limitations:
Different standardised instruments were used across countries, which may affect comparability.
The study's cross-sectional design limits causal inferences.
Conclusion:
The findings suggest the importance of early identification and culturally responsive supports to improve wellbeing for both autistic children and their parents.
Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.